Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 14 | 2025 | 165 | 6.810 |
Why?
|
| Apolipoprotein E4 | 7 | 2025 | 76 | 3.780 |
Why?
|
| Alzheimer Disease | 8 | 2025 | 250 | 3.660 |
Why?
|
| Aged | 34 | 2025 | 956 | 3.380 |
Why?
|
| Cognition Disorders | 12 | 2018 | 175 | 3.350 |
Why?
|
| Cognition | 13 | 2024 | 220 | 3.070 |
Why?
|
| Female | 37 | 2025 | 1724 | 3.040 |
Why?
|
| Male | 36 | 2025 | 1860 | 3.010 |
Why?
|
| Aged, 80 and over | 22 | 2025 | 567 | 2.520 |
Why?
|
| Humans | 38 | 2025 | 2957 | 2.480 |
Why?
|
| Chicago | 17 | 2025 | 160 | 2.280 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 11 | 1.960 |
Why?
|
| tau Proteins | 3 | 2025 | 18 | 1.960 |
Why?
|
| Longitudinal Studies | 15 | 2025 | 260 | 1.770 |
Why?
|
| Neurodegenerative Diseases | 2 | 2025 | 34 | 1.690 |
Why?
|
| Aging | 6 | 2025 | 204 | 1.630 |
Why?
|
| Risk Factors | 12 | 2025 | 275 | 1.580 |
Why?
|
| Stroke | 4 | 2016 | 49 | 1.420 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 44 | 1.350 |
Why?
|
| Activities of Daily Living | 4 | 2015 | 28 | 1.230 |
Why?
|
| Prospective Studies | 8 | 2025 | 203 | 1.160 |
Why?
|
| Alleles | 4 | 2024 | 65 | 1.140 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 11 | 1.090 |
Why?
|
| Memory Disorders | 2 | 2024 | 33 | 0.980 |
Why?
|
| Cohort Studies | 8 | 2025 | 233 | 0.950 |
Why?
|
| Lipids | 1 | 2025 | 13 | 0.880 |
Why?
|
| Social Isolation | 1 | 2025 | 8 | 0.870 |
Why?
|
| Loneliness | 1 | 2025 | 20 | 0.870 |
Why?
|
| Blood Pressure | 1 | 2024 | 24 | 0.860 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2024 | 5 | 0.860 |
Why?
|
| Incidence | 7 | 2025 | 110 | 0.860 |
Why?
|
| Diet, Mediterranean | 1 | 2024 | 12 | 0.860 |
Why?
|
| Disability Evaluation | 3 | 2013 | 23 | 0.830 |
Why?
|
| Dietary Fats | 1 | 2024 | 14 | 0.820 |
Why?
|
| Depression | 2 | 2014 | 59 | 0.770 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 147 | 0.730 |
Why?
|
| Biomarkers | 3 | 2025 | 101 | 0.630 |
Why?
|
| Geriatric Assessment | 3 | 2015 | 38 | 0.610 |
Why?
|
| Disease Progression | 6 | 2017 | 99 | 0.530 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 34 | 0.520 |
Why?
|
| Art | 1 | 2016 | 1 | 0.500 |
Why?
|
| Music | 1 | 2016 | 3 | 0.500 |
Why?
|
| Diabetes Complications | 1 | 2016 | 10 | 0.490 |
Why?
|
| Mortality | 1 | 2016 | 13 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 28 | 0.480 |
Why?
|
| Independent Living | 3 | 2025 | 29 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 92 | 0.470 |
Why?
|
| United States | 5 | 2024 | 243 | 0.470 |
Why?
|
| Dementia | 3 | 2024 | 73 | 0.460 |
Why?
|
| Mobility Limitation | 1 | 2015 | 7 | 0.450 |
Why?
|
| Time Factors | 5 | 2017 | 208 | 0.440 |
Why?
|
| Motor Activity | 1 | 2015 | 53 | 0.440 |
Why?
|
| Genotype | 3 | 2024 | 85 | 0.430 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 9 | 0.420 |
Why?
|
| Dopamine Agents | 1 | 2014 | 3 | 0.410 |
Why?
|
| Memantine | 1 | 2014 | 2 | 0.410 |
Why?
|
| Vitamin E | 1 | 2014 | 13 | 0.410 |
Why?
|
| Antioxidants | 1 | 2014 | 17 | 0.410 |
Why?
|
| Body Mass Index | 1 | 2014 | 64 | 0.410 |
Why?
|
| Obesity | 1 | 2014 | 38 | 0.400 |
Why?
|
| Neuropsychological Tests | 6 | 2018 | 238 | 0.400 |
Why?
|
| Health Status Disparities | 1 | 2013 | 7 | 0.390 |
Why?
|
| Disabled Persons | 1 | 2012 | 9 | 0.360 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 46 | 0.350 |
Why?
|
| Linear Models | 3 | 2016 | 39 | 0.350 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 46 | 0.250 |
Why?
|
| Memory, Episodic | 2 | 2017 | 22 | 0.250 |
Why?
|
| Triglycerides | 1 | 2025 | 11 | 0.220 |
Why?
|
| Cholesterol | 1 | 2025 | 18 | 0.220 |
Why?
|
| Heterozygote | 1 | 2025 | 48 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 5 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 6 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 6 | 0.220 |
Why?
|
| Hypertension | 1 | 2024 | 13 | 0.220 |
Why?
|
| Risk Assessment | 1 | 2024 | 51 | 0.210 |
Why?
|
| Age of Onset | 2 | 2013 | 22 | 0.190 |
Why?
|
| Cognitive Aging | 2 | 2018 | 27 | 0.160 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 29 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2016 | 13 | 0.140 |
Why?
|
| Middle Aged | 3 | 2016 | 792 | 0.140 |
Why?
|
| Neuropathology | 1 | 2018 | 16 | 0.140 |
Why?
|
| Confidence Intervals | 1 | 2017 | 13 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 24 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 32 | 0.130 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2016 | 5 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.130 |
Why?
|
| Parity | 1 | 2016 | 1 | 0.130 |
Why?
|
| Reproduction | 1 | 2016 | 1 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 1 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 6 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 11 | 0.120 |
Why?
|
| Reading | 1 | 2016 | 4 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 16 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 142 | 0.120 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 6 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 14 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2015 | 20 | 0.110 |
Why?
|
| Gait | 1 | 2015 | 36 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 8 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 7 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 8 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 14 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 51 | 0.110 |
Why?
|
| Overweight | 1 | 2014 | 17 | 0.100 |
Why?
|
| Interview, Psychological | 1 | 2014 | 4 | 0.100 |
Why?
|
| Intelligence Tests | 1 | 2014 | 6 | 0.100 |
Why?
|
| Life Style | 1 | 2014 | 19 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 34 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 24 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 23 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 27 | 0.100 |
Why?
|
| Hospitalization | 1 | 2013 | 49 | 0.100 |
Why?
|
| Brain | 2 | 2024 | 202 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 75 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 105 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 9 | 0.050 |
Why?
|
| Copper | 1 | 2024 | 11 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2024 | 13 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 28 | 0.050 |
Why?
|
| Community Health Planning | 1 | 2018 | 5 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 1 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 2 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 6 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 50 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 4 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2016 | 65 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 4 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 8 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 7 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 12 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 53 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 32 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 95 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 2 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2013 | 167 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 794 | 0.020 |
Why?
|